Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series

Neurosurgical Focus
Pamela S JonesWilliam T Curry

Abstract

OBJECT In patients with large or symptomatic brain lesions from metastatic melanoma, the value of resection of metastases to facilitate administration of systemic ipilimumab therapy has not yet been described. The authors undertook this study to investigate whether craniotomy creates the opportunity for patients to receive and benefit from ipilimumab who would otherwise succumb to brain metastasis prior to the onset of regression. METHODS All patients with metastatic melanoma who received ipilimumab and underwent craniotomy for metastasis resection between 2008 and 2014 at the Massachusetts General Hospital were identified through retrospective chart review. The final analysis included cases involving patients who underwent craniotomy within 3 months prior to initiation of therapy or up to 6 months after cessation of ipilimumab administration. RESULTS Twelve patients met the inclusion criteria based on timing of therapy (median age 59.2). The median number of metastases at the time of craniotomy was 2. The median number of ipilimumab doses received was 4. Eleven of 12 courses of ipilimumab were stopped for disease progression, and 1 was stopped for treatment-induced colitis. Eight of 12 patients had improvement in their perform...Continue Reading

References

Dec 10, 2003·Mayo Clinic Proceedings·Robert R McWilliamsSvetomir N Markovic
Mar 31, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K M FifeJ F Thompson
Apr 13, 2004·Current Opinion in Oncology·Ahmad A Tarhini, Sanjiv S Agarwala
Jun 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sanjiv S AgarwalaElaine M Rankin
Feb 9, 2006·Current Opinion in Immunology·Karl S PeggsJames P Allison
Oct 9, 2007·Cancer Treatment Reviews·Philip LuiThomas R Einarson
Sep 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Chrysoula I LiakouPadmanee Sharma
Feb 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hong ChenPadmanee Sharma
Nov 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jedd D WolchokF Stephen Hodi
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Nov 16, 2010·Seminars in Oncology·Margaret K CallahanJames P Allison
Jun 7, 2011·The New England Journal of Medicine·Paul B ChapmanUNKNOWN BRIM-3 Study Group
Mar 30, 2012·The Lancet Oncology·Kim MargolinF Stephen Hodi
Mar 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paolo A AsciertoJedd D Wolchok
May 21, 2013·Case Reports in Oncology·Georg FeldmannMarie von Lilienfeld-Toal
Sep 14, 2013·Journal of the National Comprehensive Cancer Network : JNCCN·Priscilla K BrastianosKevin S Oh

❮ Previous
Next ❯

Citations

Oct 5, 2019·International Journal of Cancer. Journal International Du Cancer·Mark P van OpijnenEllen H W Kapiteijn
Feb 24, 2019·The Oncologist·Christopher Alvarez-BreckenridgePriscilla K Brastianos
Apr 18, 2020·Neurosurgery·Elisa Aquilanti, Priscilla K Brastianos
Apr 19, 2017·Current Oncology Reports·Aaron C TanMustafa Khasraw
May 23, 2017·Therapeutic Advances in Medical Oncology·Tresa McGranahanSeema Nagpal
Jul 7, 2016·Deutsches Ärzteblatt International·Kirsten SchmiederStephanie Combs
Apr 25, 2021·Brain : a Journal of Neurology·Jawad FaresMaciej S Lesniak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.